Cigna pays over the odds for uncertain benefit

Friday, 09 Mar, 2018

The Wisconsin-based Thompson Investment Mgmt has invested 1.45% in Express Scripts Holding Company (NASDAQ:ESRX). Cornerstone Advsrs Incorporated holds 3,438 shares or 0.15% of its portfolio. Moneta Gru Investment Advsr Ltd Liability invested 0.08% of its portfolio in Express Scripts Holding Company (NASDAQ:ESRX). Triangle Wealth Mgmt holds 0.24% or 6,367 shares.

Shares of Express Scripts jumped 20 percent to $88.44 at 7:07 premarket trading in NY, while shares of Cigna declined 4.8 percent to $185. Express Scripts has a consensus rating of "Hold" and a consensus price target of $81.53. Acquiring Express Scripts will allow Cigna to offer a full suite of different services at many locations, offering more options for members. Amalgamated Commercial Bank owns 8,389 shares or 0.01% of their USA portfolio. Cibc reported 0.01% in Express Scripts Holding Company (NASDAQ:ESRX). Pnc Financial Group Inc stated it has 8,043 shares.

Express Scripts declared that its board has initiated a stock repurchase plan on Monday, December 18th that permits the company to repurchase 45,000,000 outstanding shares.

The TTM operating margin for the company stands at 5.5%.

WARNING: This report was first posted by and is owned by of About 23.26 million shares traded or 450.76% up from the average. Camden National Corporation (NASDAQ:CAC) has risen 42.48% since March 8, 2017 and is uptrending. It has underperformed by 33.62% the S&P500.

Cigna Corp.CI has announced that it will buy Express Scripts Holding Co., ESRX a pharmacy benefits provider and other medical servcies. Therefore 46% are positive.

If you are a shareholder of Express Scripts and believe the proposed buyout price is too low or you're interested in learning more about the investigation or your legal rights and remedies, please contact lead analyst Jim Baker ([email protected]) at 619-814-4471. Finally, Mizuho set a $86.00 target price on Express Scripts and gave the stock a "hold" rating in a research report on Wednesday, January 24th. The stock decreased 1.56% or $1.16 during the last trading session, reaching $73.42. Jefferies Group has a "Hold" rating on the stock. The stock of Express Scripts Holding Company (NASDAQ:ESRX) earned "Outperform" rating by Robert W. Baird on Friday, December 15. Barclays Capital maintained it with "Overweight" rating and $87 target in Wednesday, July 27 report. The firm has "Neutral" rating by Bank of America given on Tuesday, August 11. SELL rating has been given by 1 analyst (s) and 2 analyst (s) given BUY rating to the stock.

"Cigna-Express Scripts by itself isn't anywhere close to a revolution", he says.

Pharmacy benefits manager Express Scripts jumped 10 percent Thursday after it agreed to be bought by health insurer Cigna for $52 billion.

The deal includes Cigna's assumption of approximately $15 billion in Express Scripts debt. In Express Scripts, Cigna would acquire a pharmacy benefits manager with a market value of about $41 billion that negotiates prices with drugmakers for insurers and employers. The company has market cap of $46.21 billion.

Congressional Republicans and business leaders oppose the tariffs and have pushed for the administration to take a more measured approach that would invite less backlash from other countries. It has a 13.39 P/E ratio.

The changes across the health-care landscape come amid widespread frustration among US businesses and individuals over the complexity of a system in which doctors, hospitals, insurers and pharmaceutical companies have different, often competing, interests.